Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and Mesa, Ariz.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
